Bioinformatics Services Market Overview: Global Industry to Reach USD 15.2 Billion by 2035
The Bioinformatics Services Market is witnessing significant expansion as pharmaceutical companies, biotechnology firms, and research institutions increasingly depend on computational technologies to interpret complex biological data. According to Dimension Market Research, the Global Bioinformatics...
The global Molecular Cytogenetics Market was estimated at USD 2.40 billion in 2024 and is projected to reach USD 6.39 billion by 2033, expanding at a CAGR of 11.7% from 2025 to 2033. Market growth is driven by the increasing application of molecular cytogenetic techniques in clinical diagnostics and research, particularly for oncology, genetic disorders, and prenatal testing. The growing use of...
Mass spectrometry is moving beyond its traditional role as a laboratory analytical technique and becoming an increasingly important part of pharmaceutical research, biotechnology, proteomics, diagnostics, and other molecular investigations. The global Mass Spectrometry Market was valued at USD 7.3 billion in 2025 and is projected to reach USD 13.2 billion by 2033, expanding at a CAGR of 7.6%...
Overview:
The Cell Surface Markers Market is expanding as biomedical research increasingly relies on accurate identification and characterization of different cell populations. Cell surface markers are proteins, glycoproteins, and other molecules expressed on cell membranes that help researchers distinguish cell types, evaluate cellular states, and understand biological functions. The market...
The global computational biology market was valued at USD 7.08 billion in 2025 and is projected to grow from USD 7.99 billion in 2026 to USD 21.07 billion by 2034 , recording a CAGR of 12.88% during 2026-2034 . North America dominated the market with a 39.8% share in 2025 , while Europe is expected to register the fastest CAGR of 18.91% .
Market Size (2025): USD 7.08 Billion
Market...
The role of proteomics is changing as life sciences research moves toward more detailed and personalized understanding of biology. Instead of examining proteins in isolation, researchers are increasingly looking at expression patterns, interactions, biomarkers, and molecular pathways to understand disease and therapeutic response. This broader role is creating new demand for technologies that...
The biosensors market is no longer confined to traditional diagnostic laboratories. Sensors that interact with biological signals are appearing in wearable devices, point-of-care systems, research platforms, food analysis, agriculture, environmental monitoring, and other specialized applications. This diversification is giving the industry a wider commercial base while healthcare continues to...
The neurological biomarkers market is entering a transformative phase as healthcare and pharmaceutical research increasingly seek faster, more precise, and less invasive ways to understand neurological disorders. Biomarkers are becoming important not only for diagnosis but also for determining disease progression, evaluating treatment response, supporting patient stratification, and improving...
Digital pathology is shifting from conventional slide-based workflows toward connected, software-driven, and AI-enabled diagnostic environments. The global Digital Pathology Market reached USD 1.5 billion in 2025 and is expected to grow to USD 3.0 billion by 2033, registering an 8.6% CAGR from 2026 to 2033.
The transformation is being shaped by rising...
Lipids play a vital role in biological membranes. They provide a barrier for almost all cellular structures and act as dynamic building blocks, enabling certain membrane proteins to function efficiently and facilitating signal transduction. In addition to their involvement in metabolism and energy conversion, lipids are also involved in various developmental processes, such as cell growth and...
The enzyme-linked immunosorbent assay (ELISA) was independently developed in 1971 by Engall and Perlmann and by van Weemen and Schuurs with the aim of avoiding the problems associated with radioimmunoassays. Since then, ELISA has become a widely used method for detecting polyclonal and monoclonal antibodies in biological fluids or culture media.
Offering advantages such as high specificity,...
The global Biosensors Market size was valued at USD 32.2 billion in 2025 and is projected to grow from USD 34.7 billion in 2026 to USD 64.0 billion by 2033, at a CAGR of 9.1% from 2026 to 2033. North America dominated the market, accounting for a 42.6% revenue share in 2025. The increasing prevalence of chronic diseases, growing demand for compact diagnostic...